Tag Archives: immunogenicity risk assessment

immuno-screening-mab

Screening for Immunogenicity: Immunotherapy Challenges and Predictive Approaches Applied to Therapeutic Proteins 

As an expert in immunogenicity screening, EpiVax’s CEO/CSO, Dr. Annie De Groot, will be conducting a training on state of the art methods of in silico and in vitro analysis to assess immunogenic risk of therapeutic proteins. Please join us April 5th in … Continue reading

Posted in Events, Featured | Tagged , , , , , , , , , , , | Leave a comment
scott

EpiVax Attending Immunogenicity Summit in DC – Presenting 3 Posters!

EpiVax will be attending the upcoming Immunogenicity Summit in DC. EpiVax’ BDA, Anthony Marcello, will be presenting 3 posters (see below) on behalf of the EpiVax science team. Additionally, one of EpiVax’ Tregitope collaborators, Dr. David W. Scott, will be … Continue reading

Posted in Events | Tagged , , , , , , , , , , , , , , , , , , , , | Leave a comment